Share
University Hospital Bristol has presented groundbreaking results at the British Radiation Safety Society (BRSS) conference, showcasing the use of TrueInvivo’s® DOSEmapper™ technology in gamma knife radiosurgery. The innovative micro silica bead TLD system provided precise dose measurements, ensuring accurate delivery and improved patient safety in stereotactic radiosurgery.
This marks a significant advancement in dosimetry, highlighting the potential of DOSEmapper™ to enhance radiation safety and accuracy in complex treatments.
Related Posts
TrueInvivo's implant improves cancer treatment accuracy, accessible globally, supported by UKTI Sirius Programme.
George Sutherland appointed TRUEinvivo Ltd.'s first Chairman, bringing extensive experience in medical devices and corporate finance.
Dr. Shakardokht Jafari named 2024 Innovator of the Year at Dynamic Awards in Brighton's Grand Hotel.
TRUEinvivo® receives CE Mark for DOSEmapper Reader, automating radiotherapy dose measurement for enhanced accuracy.
